• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医护人员中不同新冠病毒疫苗的免疫原性和保护效力比较:我们的“白衣战士”得到保护了吗?

Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?

作者信息

Souan Lina, Sughayer Maher A, Abualhour Maha M, Siag Mahmoud, Al-Badr Sara, Al-Atrash Tareq

机构信息

Department of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, Jordan.

出版信息

Vaccines (Basel). 2022 Apr 20;10(5):642. doi: 10.3390/vaccines10050642.

DOI:10.3390/vaccines10050642
PMID:35632398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9143190/
Abstract

Background: The effective immunization of healthcare workers (HCWs) plays a vital role in preventing the spread of SARS-CoV-2 infection during the coronavirus disease 2019 (COVID-19) pandemic. There is limited data on the immune response to vaccination among HCWs. We aim to determine seroprevalence rates and neutralizing IgG antibody response to various immunizations among HCWs. Methods: This study was conducted between July and September 2021, in which blood samples were obtained from HCWs and SARS-CoV-2 IgG neutralizing antibodies were measured. Data regarding vaccination status with Pfizer/BioNTech, Sinopharm, or AstraZeneca vaccines, occupation, and prior COVID-19 infection were analyzed. Results: COVID-19 infection post-vaccination was associated with higher mean antibody titers, regardless of vaccine type. Pfizer/BioNTech vaccination produced higher mean antibody titers for HCWs with prior COVID-19 infection (p < 0.00001) than other types of vaccines. Although 96% of HCWs were vaccinated, 3% were seronegative. For HCWs who were seropositive, there were no significant differences between the mean antibody titers when comparing occupations and blood indices. Conclusion: Awareness of the immunity status of HCWs is key to protecting this important group against SARS-CoV-2, especially those without prior COVID-19 infection. Further public health efforts regarding booster vaccination for HCWs are crucial to provide necessary antibody protection.

摘要

背景

在2019冠状病毒病(COVID-19)大流行期间,医护人员(HCWs)的有效免疫接种在预防严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染传播方面发挥着至关重要的作用。关于医护人员对疫苗接种的免疫反应的数据有限。我们旨在确定医护人员中各种免疫接种后的血清阳性率和中和IgG抗体反应。方法:本研究于2021年7月至9月进行,采集医护人员的血样并检测SARS-CoV-2 IgG中和抗体。分析了关于辉瑞/生物新技术公司、国药集团或阿斯利康疫苗的接种状况、职业和既往COVID-19感染的数据。结果:无论疫苗类型如何,接种疫苗后感染COVID-19均与较高的平均抗体滴度相关。对于既往感染过COVID-19的医护人员,辉瑞/生物新技术公司疫苗接种产生的平均抗体滴度(p < 0.00001)高于其他类型的疫苗。尽管96%的医护人员接种了疫苗,但3%的人血清学检测呈阴性。对于血清学检测呈阳性的医护人员,比较职业和血液指标时,平均抗体滴度之间没有显著差异。结论:了解医护人员的免疫状态是保护这一重要群体免受SARS-CoV-2感染的关键,尤其是那些既往未感染过COVID-19的人员。针对医护人员加强接种的进一步公共卫生努力对于提供必要的抗体保护至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfdf/9143190/67e5a3223063/vaccines-10-00642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfdf/9143190/51e3a8aebb4d/vaccines-10-00642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfdf/9143190/67e5a3223063/vaccines-10-00642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfdf/9143190/51e3a8aebb4d/vaccines-10-00642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfdf/9143190/67e5a3223063/vaccines-10-00642-g002.jpg

相似文献

1
Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?医护人员中不同新冠病毒疫苗的免疫原性和保护效力比较:我们的“白衣战士”得到保护了吗?
Vaccines (Basel). 2022 Apr 20;10(5):642. doi: 10.3390/vaccines10050642.
2
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.不同类型疫苗的抗 SARS-CoV-2 RBD IgG 抗体反应的有效性和持续时间比较:对疫苗策略的影响。
Vaccine. 2022 May 3;40(20):2841-2847. doi: 10.1016/j.vaccine.2022.03.069. Epub 2022 Apr 1.
3
Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco).摩洛哥马拉喀什接种疫苗的医护人员中 SARS-CoV-2 抗体的血清阳性率。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221133697. doi: 10.1177/03946320221133697.
4
[COVID-19 infections and effectiveness of the vaccination among healthcare workers].[医护人员中的新冠病毒感染情况及疫苗接种效果]
Orv Hetil. 2023 Feb 5;164(5):163-171. doi: 10.1556/650.2023.32709.
5
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea.疫苗诱导的中和抗体滴度动力学和对野生型 SARS-CoV-2 和 Delta 变异株的估计保护免疫力:一项在韩国比较三种 COVID-19 疫苗接种方案的前瞻性全国队列研究。
Front Immunol. 2022 Sep 23;13:968105. doi: 10.3389/fimmu.2022.968105. eCollection 2022.
6
[Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].[卡斯蒂利亚-莱昂社会医疗中心工作人员接种辉瑞/生物科技公司的BNT162b2 mRNA疫苗后对严重急性呼吸综合征冠状病毒2的体液免疫。]
Rev Esp Salud Publica. 2021 Oct 25;95:e202110141.
7
The Longitudinal Analysis on the Anti-SARS-CoV-2 Antibodies among Healthcare Workers in Poland-Before and after BNT126b2 mRNA COVID-19 Vaccination.波兰医护人员接种BNT126b2 mRNA新冠疫苗前后抗SARS-CoV-2抗体的纵向分析
Vaccines (Basel). 2022 Sep 20;10(10):1576. doi: 10.3390/vaccines10101576.
8
Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.医护人员对灭活的 SARS-CoV-2 疫苗的抗体反应,印度尼西亚。
Int J Infect Dis. 2021 Dec;113:15-17. doi: 10.1016/j.ijid.2021.09.078. Epub 2021 Oct 3.
9
[The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].科兴新冠疫苗第二针可能导致曾感染新冠病毒者抗体水平下降
Mikrobiyol Bul. 2022 Jan;56(1):139-142. doi: 10.5578/mb.20229913.
10
Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?接种 COVID-19 疫苗后,人乳中能否检测到 SARS-CoV-2 抗体?
J Pediatric Infect Dis Soc. 2022 Apr 30;11(4):126. doi: 10.1093/jpids/piac024.

引用本文的文献

1
Enhanced RBD-Specific Antibody Responses and SARS-CoV-2-Relevant T-Cell Activity in Healthcare Workers Following Booster Vaccination.加强疫苗接种后医护人员中RBD特异性抗体反应增强及与SARS-CoV-2相关的T细胞活性
Curr Issues Mol Biol. 2024 Oct 2;46(10):11124-11135. doi: 10.3390/cimb46100660.
2
Evaluation of Seroconversion Rate Following SARS COV 2 Vaccination in Health Care Workers at Shahid Beheshti University of Medical Sciences.沙希德·贝赫什提医科大学医护人员接种新型冠状病毒疫苗后的血清转化率评估
Avicenna J Med Biotechnol. 2023 Oct-Dec;15(4):258-263. doi: 10.18502/ajmb.v15i4.13501.
3
COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation-A Single-Center Study.

本文引用的文献

1
Higher vaccination rates predict reduction in SARS-CoV-2 transmission across the United States.较高的疫苗接种率可预测美国 SARS-CoV-2 传播的减少。
Infection. 2022 Oct;50(5):1255-1266. doi: 10.1007/s15010-022-01802-1. Epub 2022 Mar 22.
2
Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2.随时间推移医护人员中有无接触 SARS-CoV-2 者对 BBIBP-CorV 疫苗的体液免疫反应。
Mol Immunol. 2022 Mar;143:94-99. doi: 10.1016/j.molimm.2022.01.009. Epub 2022 Jan 17.
3
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia.
癌症患者中COVID-19抗体血清转化:治疗中断的影响——一项单中心研究
Vaccines (Basel). 2023 Oct 30;11(11):1659. doi: 10.3390/vaccines11111659.
蒙古国四种 SARS-CoV-2 疫苗抗体反应的直接比较。
Cell Host Microbe. 2021 Dec 8;29(12):1738-1743.e4. doi: 10.1016/j.chom.2021.11.004. Epub 2021 Nov 12.
4
Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign.定量血清学评估是 COVID-19 疫苗接种运动中的一项有价值的工具。
Clin Chem Lab Med. 2021 Oct 7;59(12):2019-2026. doi: 10.1515/cclm-2021-0364. Print 2021 Nov 25.
5
Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.德国医护人员在 COVID-19 大流行第三波末期 SARS-CoV-2 感染率低且疫苗诱导的免疫力高。
Int J Hyg Environ Health. 2021 Sep;238:113851. doi: 10.1016/j.ijheh.2021.113851. Epub 2021 Sep 25.
6
Assessing COVID-19 Vaccine Uptake and Effectiveness Through the North West London Vaccination Program: Retrospective Cohort Study.通过伦敦西北部疫苗接种计划评估新冠疫苗接种率及有效性:回顾性队列研究
JMIR Public Health Surveill. 2021 Sep 17;7(9):e30010. doi: 10.2196/30010.
7
Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study.在接种疫苗前,比利时医院医护人员中抗 SARS-CoV-2 抗体的流行率和发生率:一项前瞻性队列研究。
BMJ Open. 2021 Jun 29;11(6):e050824. doi: 10.1136/bmjopen-2021-050824.
8
Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic.健康献血者中 SARS-CoV-2 抗体血清阳性率的急剧上升:大流行的演变。
Int J Infect Dis. 2021 Jun;107:116-120. doi: 10.1016/j.ijid.2021.04.059. Epub 2021 Apr 20.
9
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗(阿斯利康)对 SARS-CoV-2 的安全性和有效性:巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.